The Target ALS Global Natural History Study: Cross-platform proteomics to accelerate biofluid biomarker and drug target discovery in amyotrophic lateral sclerosis

Daisuke Yasui, Daniel Weatherill, Laura Dugom, Sophia Weiner, Lathika Gopalakrishnan, Huy Tran, Björn Oskarsson, Kyra Nagle, Timothy Miller, Gilbert Gutierrez, John Ravits, Benjamin Hoover, Matthew Harms, Neil Shneider, Lizzi Neylon, Whitney Dailey, Shafeeq Ladha, Cassandra Holmes, Joseph Lee, Nicholas Streicher, Shakti Nayar, Brent T. Harris, Manish Raisinghani, Henrik Zetterberg, Johan Gobom, Amy Easton, Robert Bowser, Cindy V. Ly

Open source

DOI: 10.64898/2026.06.13.26355379
Published: 2026-06-23
Container: Not recorded
Publisher: openRxiv
Open access: unknown

Credibility signals

uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
cautionPublication version: Identified as a preprint; peer review and later versions may change the record. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.64898/2026.06.13.26355379,
  title = {The Target ALS Global Natural History Study: Cross-platform proteomics to accelerate biofluid biomarker and drug target discovery in amyotrophic lateral sclerosis},
  author = {Daisuke Yasui and Daniel Weatherill and Laura Dugom and Sophia Weiner and Lathika Gopalakrishnan and Huy Tran and Björn Oskarsson and Kyra Nagle and Timothy Miller and Gilbert Gutierrez and John Ravits and Benjamin Hoover and Matthew Harms and Neil Shneider and Lizzi Neylon and Whitney Dailey and Shafeeq Ladha and Cassandra Holmes and Joseph Lee and Nicholas Streicher and Shakti Nayar and Brent T. Harris and Manish Raisinghani and Henrik Zetterberg and Johan Gobom and Amy Easton and Robert Bowser and Cindy V. Ly},
  year = {2026},
  doi = {10.64898/2026.06.13.26355379},
  url = {https://doi.org/10.64898/2026.06.13.26355379}
}

RIS

TY  - JOUR
TI  - The Target ALS Global Natural History Study: Cross-platform proteomics to accelerate biofluid biomarker and drug target discovery in amyotrophic lateral sclerosis
AU  - Daisuke Yasui
AU  - Daniel Weatherill
AU  - Laura Dugom
AU  - Sophia Weiner
AU  - Lathika Gopalakrishnan
AU  - Huy Tran
AU  - Björn Oskarsson
AU  - Kyra Nagle
AU  - Timothy Miller
AU  - Gilbert Gutierrez
AU  - John Ravits
AU  - Benjamin Hoover
AU  - Matthew Harms
AU  - Neil Shneider
AU  - Lizzi Neylon
AU  - Whitney Dailey
AU  - Shafeeq Ladha
AU  - Cassandra Holmes
AU  - Joseph Lee
AU  - Nicholas Streicher
AU  - Shakti Nayar
AU  - Brent T. Harris
AU  - Manish Raisinghani
AU  - Henrik Zetterberg
AU  - Johan Gobom
AU  - Amy Easton
AU  - Robert Bowser
AU  - Cindy V. Ly
PY  - 2026
DO  - 10.64898/2026.06.13.26355379
UR  - https://doi.org/10.64898/2026.06.13.26355379
ER  -

APA

Yasui, D., Weatherill, D., Dugom, L., Weiner, S., Gopalakrishnan, L., Tran, H., Oskarsson, B., Nagle, K., Miller, T., Gutierrez, G., Ravits, J., Hoover, B., Harms, M., Shneider, N., Neylon, L., Dailey, W., Ladha, S., Holmes, C., Lee, J., Streicher, N., Nayar, S., Harris, B. T., Raisinghani, M., Zetterberg, H., Gobom, J., Easton, A., Bowser, R., & Ly, C. V. (2026). The Target ALS Global Natural History Study: Cross-platform proteomics to accelerate biofluid biomarker and drug target discovery in amyotrophic lateral sclerosis. https://doi.org/10.64898/2026.06.13.26355379

Source records

crossref · retrieved 2026-09-25T08:42:57.877Z